FINWIRES · TerminalLIVE
FINWIRES

ATEX Resources Maintained at Buy at Stifel Canada After Valeriano Site Vist; Price Target Kept at C$5.25

By

Stifel Canada on Monday reiterated its buy rating on the shares of ATEX Resources (ATX.V) and its C$5.25 price target following a visit to the company's Valeriano Project in Chile.

"Late last week we toured ATEX's Valeriano Project, including offices in Vallenar, core repository, and site camp, alongside in depth seminars on geology, infrastructure, community engagement, and exploration strategy by ATEX's team. Our main takeaways are twofold in i) scale of the emerging Valeriano/El Encierro district, where ATEX's new acquisition of Nuevo Horizonte could put a stretch target of ~50-60Blbs CuEq, which would firmly place it as one of the largest undeveloped PCD clusters wholly in Chile, and ii) an exploration process that is improving in efficiency, where we think learnings from ATEX's ability to fingerprint Valeriano can be applied to Nuevo Horizonte, aiding the process. While we are approaching the winding down of drilling season, we would note ATX shares are pricing in just the porphyry resource at Valeriano utilizing the 2024 FdS multiple, with minimal value attributed to B2B (SOTP = C$6.00/sh upside scenario)," analyst Cole McGill wrote.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $3.57, Change: $+0.07, Percent Change: +2.15%

Related Articles

Research

Research Alert: CFRA Keeps Buy Rating On Shares Of Abbvie Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target price to $255 from $275, 15.8x our 2026 EPS view. This is above ABBV's 10-year historical forward P/E average of 12.0x, justified by the company's improving long-term growth prospects. We lower our 2026 EPS forecast to $14.02 from $14.29 as we adjust our Q1 EPS estimate to $2.63 from $3.05. The company disclosed a new IPR&D and milestone expense of $744M last week related to collaborations, licensing agreements, and asset acquisitions, which will dilute Q1 EPS. We keep our 2026 EPS estimate at $16.13. The company is expected to report Q1 results before market open on April 29, when we expect to get more color on Q1 performance and expectations for the remainder of 2026.

$ABBV
Research

Research Alert: CFRA Upgrades View On Pnr Shares From Buy To Strong Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Following a nearly 15% drop in shares YTD, we view shares as being attractively valued with a healthy margin of safety. We attribute the decline this year to ongoing weakness in residential markets (PNR's largest end-market exposure) and conservative guidance. PNR shares are trading below their historical multiple average and well below peers on a forward P/E (NTM) basis. We see headwinds as being more than priced in at this point, with upside in shares if residential markets enter even a modest recovery. Our upgrade is made in part due to indications that repair and remodeling investment is beginning to recover in U.S. markets, which bodes well for PNR's Pools business looking to Q1. Assuming residential markets remain roughly flat, we see new products and efficiency initiatives supporting PNR's earnings quality in 2026. We reiterate our 12-month target of $130, valuing shares at 22x (below peer average of ~24x) our 2027 EPS outlook of $5.92 (unchanged estimate; 2026 EPS of $5.40 is also unchanged).

$PNR
Research

Research Alert: CFRA Upgrades Opinion On Shares Of Rok To Buy From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We upgrade our view on shares of ROK to Buy from Hold and adjust our 12-month target to $465 from $430, valuing shares at 34x our FY 27 EPS outlook of $13.69 (up from $13.47; FY 26 EPS view adjusted to $12.19 from $12.02), roughly in line with the company's long-term historical multiple average. Safety stockpiling of inventory amid tariff concerns and supply chain pressures has thrust the manufacturing sector back into expansion, with orders and production currently in a state of growth. Additionally, we believe that as reshored manufacturing capacity increasingly comes online, that capital investment will ramp up specifically for automation systems and controls. As demand recovery broadens out, we believe that pricing realization will accompany volume growth and drive earnings expansion into the double digits for FY 26 and FY 27. Outside of market dynamics, we anticipate internal efforts to enhance efficiency and cut exposure to lower value products will bear fruit over the next several quarters.

$ROK